Todd Schlesinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Todd Schlesinger has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
Carol Stegura
School of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
4 shared publicationsLuke Broughton
School of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
4 shared publications- Michael Howard Gold
Gold Skin Care Center Nashville Tennessee USA
4 shared publications Alan Snyder
Department of Dermatology and Dermatologic Surgery Medical University of South Carolina Charleston South Carolina USA
3 shared publications- Ayman Grada
Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, USA
3 shared publications Luna Samman
Lake Erie College of Osteopathic Medicine, Bradenton, Florida, USA
3 shared publications
Latest Publications
- Open Access
- 15 November 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (11)
Clinical Evidence for Macrocystis pyrifera Ferment‐Containing Serum in Barrier Repair and Skin Tone Improvement
Background: Skin aging arises from intrinsic factors and is accelerated by extrinsic factors such as ultraviolet exposure and pollution, leading to inflammation, barrier impairment, and pigmentary changes. Energy‐based devices and chemical peels are widely used for facial rejuvenation, but post‐procedural recovery remains challenging due to barrier disruption and risk of dyschromia. Aims: This review evaluates the clinical evidence for Macrocystis pyrifera ferment (MPF)‐containing serum as an adjunctive skincare approach to support pre‐ and post‐procedure recovery, focusing on anti‐inflammatory effects, barrier repair, and pigmentary improvement. Methods: A panel of eight expert dermatologists reviewed clinical data on MPF and MPF‐containing serum, focusing on its potential applications in cosmetic dermatology. This manuscript presents the clinical evidence alongside insights from the panel discussion. Results: In a clinical erythema model, pretreatment with MPF significantly reduced erythema and accelerated recovery from irritation. Twice‐daily application of MPF‐containing serum improved hydration and reduced transepidermal water loss (TEWL), with moisturization increasing by 14% at Week 4 and 16% at Week 8, and TEWL decreasing by 11% at Week 8. Tape‐stripping studies confirmed a 30% improvement in barrier resilience at Week 8. In a trial of 52 women (ages 20–62, Fitzpatrick I–VI), twice‐daily application of MPF‐containing serum progressively improved post‐inflammatory erythema and hyperpigmentation, achieving nearly a 50% reduction in spot intensity and contrast by Week 12. Benefits were measurable as early as Week 2, and all participants demonstrated improvement by study end. Conclusions: MPF‐containing serum demonstrates anti‐inflammatory, barrier‐strengthening, and dyschromia‐improving properties, making it a safe and effective adjunct to dermatologic procedures. While current findings support its utility in post‐procedural care, further large‐scale, diverse clinical trials are warranted.
- 15 November 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (11)
Open AccessClinical Evidence for Macrocystis pyrifera Ferment‐Containing Serum in Barrier Repair and Skin Tone Improvement
Background: Skin aging arises from intrinsic factors and is accelerated by extrinsic factors such as ultraviolet exposure and pollution, leading to inflammation, barrier impairment, and pigmentary changes. Energy‐based devices and chemical peels are widely used for facial rejuvenation, but post‐procedural recovery remains challenging due to barrier disruption and risk of dyschromia. Aims: This review evaluates the clinical evidence for Macrocystis pyrifera ferment (MPF)‐containing serum as an adjunctive skincare approach to support pre‐ and post‐procedure recovery, focusing on anti‐inflammatory effects, barrier repair, and pigmentary improvement. Methods: A panel of eight expert dermatologists reviewed clinical data on MPF and MPF‐containing serum, focusing on its potential applications in cosmetic dermatology. This manuscript presents the clinical evidence alongside insights from the panel discussion. Results: In a clinical erythema model, pretreatment with MPF significantly reduced erythema and accelerated recovery from irritation. Twice‐daily application of MPF‐containing serum improved hydration and reduced transepidermal water loss (TEWL), with moisturization increasing by 14% at Week 4 and 16% at Week 8, and TEWL decreasing by 11% at Week 8. Tape‐stripping studies confirmed a 30% improvement in barrier resilience at Week 8. In a trial of 52 women (ages 20–62, Fitzpatrick I–VI), twice‐daily application of MPF‐containing serum progressively improved post‐inflammatory erythema and hyperpigmentation, achieving nearly a 50% reduction in spot intensity and contrast by Week 12. Benefits were measurable as early as Week 2, and all participants demonstrated improvement by study end. Conclusions: MPF‐containing serum demonstrates anti‐inflammatory, barrier‐strengthening, and dyschromia‐improving properties, making it a safe and effective adjunct to dermatologic procedures. While current findings support its utility in post‐procedural care, further large‐scale, diverse clinical trials are warranted.
- 1 April 2026
- Vol. 19 (4) , 30-34
Pipeline of Devices and Aesthetics: What Is Left?
Aesthetic dermatology is experiencing a continued shift toward minimally invasive procedures with the least amount of patient downtime. Herein we focus on the advancements and evolving technologies in the development for neurotoxins, fillers, exosomes, microneedling, and microcoring devices that are currently available or in development. These treatment advancements offer dermatologists a broader range of tools, enabling more patients to pursue cosmetic treatments with greater comfort and individualized care.
- 1 April 2026
- Vol. 19 (4) , 30-34
Pipeline of Devices and Aesthetics: What Is Left?
Aesthetic dermatology is experiencing a continued shift toward minimally invasive procedures with the least amount of patient downtime. Herein we focus on the advancements and evolving technologies in the development for neurotoxins, fillers, exosomes, microneedling, and microcoring devices that are currently available or in development. These treatment advancements offer dermatologists a broader range of tools, enabling more patients to pursue cosmetic treatments with greater comfort and individualized care.
- Open Access
- 24 February 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (3) , e70755
A Single‐Center, Open‐Label Study to Evaluate the Efficacy and Tolerability of Retinal Encapsulated in a Novel Biomimetic Exosome in the Treatment of Mild‐To‐Moderate Facial Photodamage
Background: Numerous retinoid‐based skincare products are available over‐the‐counter for photodamaged and photoaged skin, but are associated with objective (e.g., erythema, dryness, flaking, edema) and subjective (e.g., itching, tingling, stinging, burning) tolerability issues. A novel retinal formulation was developed using an engineered biomimetic vegan exosome as a delivery system. The formulation also contains proprietary and potent hyaluronic acid, as well as plant‐based actives commonly used in traditional herbal medicines for their anti‐inflammatory and antioxidant properties. Aims: Evaluate the efficacy and tolerability of this biomimetic exosome‐encapsulated retinal product for treatment of mild‐to‐moderate facial photodamage. Patients/Methods: Twenty females aged 35 to 65 years, with Fitzpatrick skin types I‐VI, mild‐to‐moderate facial fine lines and wrinkles, and mild‐to‐moderate facial photodamage, were assessed at screening/baseline and weeks 2, 4, 8, and 12. Investigator‐ and participant‐assessed evaluations were performed at each visit. The primary objective was to demonstrate a decrease in the appearance of fine lines and wrinkles, erythema, as well as a reduction of overall facial photodamage after a 12‐week topical regimen. The secondary objective was to measure the frequency of adverse events throughout the study. Results: Statistically significant improvements in erythema, skin tone, skin texture, and lines/wrinkles were observed at all follow‐up visits, compared to baseline. At weeks 8 and 12, all participants (100%) displayed improvements in facial aesthetics. Most participants (19/20; 95.00%) were satisfied with the product and would recommend it to others. No product‐related adverse events were reported. Conclusions: Daily use of this “hydrating retinal” improved signs of facial photodamage with none to mild signs of skin irritation.
- 24 February 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (3) , e70755
Open AccessA Single‐Center, Open‐Label Study to Evaluate the Efficacy and Tolerability of Retinal Encapsulated in a Novel Biomimetic Exosome in the Treatment of Mild‐To‐Moderate Facial Photodamage
Background: Numerous retinoid‐based skincare products are available over‐the‐counter for photodamaged and photoaged skin, but are associated with objective (e.g., erythema, dryness, flaking, edema) and subjective (e.g., itching, tingling, stinging, burning) tolerability issues. A novel retinal formulation was developed using an engineered biomimetic vegan exosome as a delivery system. The formulation also contains proprietary and potent hyaluronic acid, as well as plant‐based actives commonly used in traditional herbal medicines for their anti‐inflammatory and antioxidant properties. Aims: Evaluate the efficacy and tolerability of this biomimetic exosome‐encapsulated retinal product for treatment of mild‐to‐moderate facial photodamage. Patients/Methods: Twenty females aged 35 to 65 years, with Fitzpatrick skin types I‐VI, mild‐to‐moderate facial fine lines and wrinkles, and mild‐to‐moderate facial photodamage, were assessed at screening/baseline and weeks 2, 4, 8, and 12. Investigator‐ and participant‐assessed evaluations were performed at each visit. The primary objective was to demonstrate a decrease in the appearance of fine lines and wrinkles, erythema, as well as a reduction of overall facial photodamage after a 12‐week topical regimen. The secondary objective was to measure the frequency of adverse events throughout the study. Results: Statistically significant improvements in erythema, skin tone, skin texture, and lines/wrinkles were observed at all follow‐up visits, compared to baseline. At weeks 8 and 12, all participants (100%) displayed improvements in facial aesthetics. Most participants (19/20; 95.00%) were satisfied with the product and would recommend it to others. No product‐related adverse events were reported. Conclusions: Daily use of this “hydrating retinal” improved signs of facial photodamage with none to mild signs of skin irritation.
- Open Access
- 7 November 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (11) , 1438
Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
Cell-mediated drug delivery systems represent a promising frontier in dermatologic therapy by offering enhanced targeting precision, prolonged drug release, and reduced systemic toxicity. These systems leverage the intrinsic properties of immune cells, stem cells, and skin-resident cells to migrate toward inflamed or diseased skin and deliver therapeutic agents in a controlled and biocompatible manner. This review explores the mechanistic foundations of cell-mediated delivery, including chemotaxis, phagocytosis, and immune modulation, and examines current applications in inflammatory skin diseases such as atopic dermatitis and psoriasis, cutaneous malignancies such as melanoma and cutaneous T-cell lymphoma, and chronic wound healing. Engineering approaches such as cell surface modification, exosome loading, and integration with gene editing technologies are also discussed. Finally, we highlight translational challenges related to immunogenicity, manufacturing scalability, and regulatory considerations, and propose future directions for clinical adoption in dermatology. This review provides a comprehensive overview of the current landscape and outlines the potential for cell-based delivery systems to transform the treatment of chronic and refractory skin diseases.
- 7 November 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (11) , 1438
Open AccessAdvances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
Cell-mediated drug delivery systems represent a promising frontier in dermatologic therapy by offering enhanced targeting precision, prolonged drug release, and reduced systemic toxicity. These systems leverage the intrinsic properties of immune cells, stem cells, and skin-resident cells to migrate toward inflamed or diseased skin and deliver therapeutic agents in a controlled and biocompatible manner. This review explores the mechanistic foundations of cell-mediated delivery, including chemotaxis, phagocytosis, and immune modulation, and examines current applications in inflammatory skin diseases such as atopic dermatitis and psoriasis, cutaneous malignancies such as melanoma and cutaneous T-cell lymphoma, and chronic wound healing. Engineering approaches such as cell surface modification, exosome loading, and integration with gene editing technologies are also discussed. Finally, we highlight translational challenges related to immunogenicity, manufacturing scalability, and regulatory considerations, and propose future directions for clinical adoption in dermatology. This review provides a comprehensive overview of the current landscape and outlines the potential for cell-based delivery systems to transform the treatment of chronic and refractory skin diseases.
- 6 September 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (12) , 2947-2949
Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy
- 6 September 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (12) , 2947-2949
Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy
- 1 April 2025
- Vol. 18 (4) , 44-50
A Non-randomized, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of 10% Aminolevulinic Acid Gel in the Expanded Field-directed Treatment of Actinic Keratosis on the Face and Scalp with Red Light Photodynamic Therapy
Dermatologists regularly encounter patients having expanded fields with numerous actinic keratosis (AK) lesions on the face and scalp. Field-directed red light photodynamic therapy (PDT) is a well-established treatment, yet published data on the safety of PDT on large areas is scarce. We aimed to evaluate the safety and tolerability of red light PDT in treating expanded AK fields on the face and scalp. This was a non-randomized, open-label, multicenter study. After lesion preparation, 6g of 10% aminolevulinic acid (ALA) gel were applied to the treatment field (60 cm2) and incubated for three hours under a light-blocking, occlusive dressing before 10-minute illumination with a red light lamp (~635nm, 37 J/cm2). Safety and tolerability were assessed throughout the study. All participants (n=100) had adverse reactions. No previously unknown effects, serious adverse events, or deaths were reported. The most frequent application site reactions were pain/burning (96.0%), exfoliation (87.0%), and erythema (86.0%). Most treatment-emergent adverse events were of mild to moderate severity and lasted slightly longer compared to those experienced after treatment of smaller areas. The mean maximum pain during PDT was 7.4±2.1 on an 11-point numeric rating scale. A transient increase in blood pressure on the day that PDT was performed was not clinically significant. Although the allowed use of pain-reducing measures might have influenced evaluation of pain, it reflects how the procedure is managed in current practice. PDT with 10% ALA gel and red light illumination on an expanded treatment field was generally well tolerated.
- 1 April 2025
- Vol. 18 (4) , 44-50
A Non-randomized, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of 10% Aminolevulinic Acid Gel in the Expanded Field-directed Treatment of Actinic Keratosis on the Face and Scalp with Red Light Photodynamic Therapy
Dermatologists regularly encounter patients having expanded fields with numerous actinic keratosis (AK) lesions on the face and scalp. Field-directed red light photodynamic therapy (PDT) is a well-established treatment, yet published data on the safety of PDT on large areas is scarce. We aimed to evaluate the safety and tolerability of red light PDT in treating expanded AK fields on the face and scalp. This was a non-randomized, open-label, multicenter study. After lesion preparation, 6g of 10% aminolevulinic acid (ALA) gel were applied to the treatment field (60 cm2) and incubated for three hours under a light-blocking, occlusive dressing before 10-minute illumination with a red light lamp (~635nm, 37 J/cm2). Safety and tolerability were assessed throughout the study. All participants (n=100) had adverse reactions. No previously unknown effects, serious adverse events, or deaths were reported. The most frequent application site reactions were pain/burning (96.0%), exfoliation (87.0%), and erythema (86.0%). Most treatment-emergent adverse events were of mild to moderate severity and lasted slightly longer compared to those experienced after treatment of smaller areas. The mean maximum pain during PDT was 7.4±2.1 on an 11-point numeric rating scale. A transient increase in blood pressure on the day that PDT was performed was not clinically significant. Although the allowed use of pain-reducing measures might have influenced evaluation of pain, it reflects how the procedure is managed in current practice. PDT with 10% ALA gel and red light illumination on an expanded treatment field was generally well tolerated.
- Open Access
- 10 January 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (1) , e16761
The Role of Exosomes in Medical Dermatology: Literature Review and Update
Background: Exosomes are extracellular vesicles, composed of a phospholipid bilayer, that are primarily derived from stem cells. The contents of exosomes can be incorporated into the tissue in which they are introduced, which presents a unique therapeutic option. Aims: Exosomes have been investigated as a treatment for a number of medical ailments, but the literature supporting these indications is inconclusive. In addition, much of the study on exosomes and their uses has been recently completed. Thus, this review summarizes the efficacy and implications of exosomes in the treatment of different dermatologic conditions. Methods: A literature review surrounding the use of exosomes for multiple medical dermatological conditions was conducted. Additionally, we present numerous practical cases in which patients had been treated with exosomes. Results: Overall, the success of exosomes in treating medical dermatologic conditions demonstrated varying efficacy in the literature, but the preliminary evidence is generally positive. The patient cases also showed satisfactory clinical outcomes but further studies and cases will be necessary to fully characterize the efficacy of exosomes and the ideal modalities for their application, including formulation, mode of distribution, and frequency of treatment. Conclusions: Exosomes may serve as an effective treatment option for wound healing, reconstruction of skin flaps, radiation dermatitis, acne vulgaris, psoriasis, atopic dermatitis, allergic contact dermatitis, lichen simplex chronicus, vulvar lichen sclerosis, systemic sclerosis, systemic lupus erythematosus, and vitiligo although additional studies are needed to confirm their efficacy and safety.
- 10 January 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (1) , e16761
Open AccessThe Role of Exosomes in Medical Dermatology: Literature Review and Update
Background: Exosomes are extracellular vesicles, composed of a phospholipid bilayer, that are primarily derived from stem cells. The contents of exosomes can be incorporated into the tissue in which they are introduced, which presents a unique therapeutic option. Aims: Exosomes have been investigated as a treatment for a number of medical ailments, but the literature supporting these indications is inconclusive. In addition, much of the study on exosomes and their uses has been recently completed. Thus, this review summarizes the efficacy and implications of exosomes in the treatment of different dermatologic conditions. Methods: A literature review surrounding the use of exosomes for multiple medical dermatological conditions was conducted. Additionally, we present numerous practical cases in which patients had been treated with exosomes. Results: Overall, the success of exosomes in treating medical dermatologic conditions demonstrated varying efficacy in the literature, but the preliminary evidence is generally positive. The patient cases also showed satisfactory clinical outcomes but further studies and cases will be necessary to fully characterize the efficacy of exosomes and the ideal modalities for their application, including formulation, mode of distribution, and frequency of treatment. Conclusions: Exosomes may serve as an effective treatment option for wound healing, reconstruction of skin flaps, radiation dermatitis, acne vulgaris, psoriasis, atopic dermatitis, allergic contact dermatitis, lichen simplex chronicus, vulvar lichen sclerosis, systemic sclerosis, systemic lupus erythematosus, and vitiligo although additional studies are needed to confirm their efficacy and safety.
- Open Access
- 8 January 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (1) , e16769
Exosomes: Historical Evolution and Emerging Roles in Dermatology
Background: Exosomes are a nanoscale extracellular vesicles derived from different cell types that have been investigated for various clinical applications, including functioning as biomarkers and use as direct therapeutics. Given the role of exosomes in multiple pathophysiologic pathways and potential practical applications, they have garnered significant interest in the scientific community but much is still unknown about their development and use. Aims: This literature review covers the background, mechanisms of action, use as biomarkers, methods of application, and direct therapeutic applications of exosomes. Methods: A literature review on the background and uses of exosomes was conducted. Key articles describing the pathophysiologic pathways and applications of exosomes were summarized and described. Results: Exosomes impact several cellular pathways which allow them to function as biomarkers for malignancy and inflammatory dermatoses and may make them useful therapeutics for skin rejuvenation, hair loss, and wound repair. Limitations of exosomes include an incomplete understanding of their functions and impacts and a lack of standardization in their production and application. Conclusions: Exosomes are a unique and novel cellular medium that offer promise as a diagnostic tool and therapy. While there are limitations to the uses of exosomes as well as our current understanding of them, further investigation may yield additional applications and a larger role in medicine for exosomes.
- 8 January 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (1) , e16769
Open AccessExosomes: Historical Evolution and Emerging Roles in Dermatology
Background: Exosomes are a nanoscale extracellular vesicles derived from different cell types that have been investigated for various clinical applications, including functioning as biomarkers and use as direct therapeutics. Given the role of exosomes in multiple pathophysiologic pathways and potential practical applications, they have garnered significant interest in the scientific community but much is still unknown about their development and use. Aims: This literature review covers the background, mechanisms of action, use as biomarkers, methods of application, and direct therapeutic applications of exosomes. Methods: A literature review on the background and uses of exosomes was conducted. Key articles describing the pathophysiologic pathways and applications of exosomes were summarized and described. Results: Exosomes impact several cellular pathways which allow them to function as biomarkers for malignancy and inflammatory dermatoses and may make them useful therapeutics for skin rejuvenation, hair loss, and wound repair. Limitations of exosomes include an incomplete understanding of their functions and impacts and a lack of standardization in their production and application. Conclusions: Exosomes are a unique and novel cellular medium that offer promise as a diagnostic tool and therapy. While there are limitations to the uses of exosomes as well as our current understanding of them, further investigation may yield additional applications and a larger role in medicine for exosomes.
- Top Cited PapersOpen Access
- 7 January 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (1) , e16766
Exosomes for Aesthetic Dermatology: A Comprehensive Literature Review and Update
Background: Exosomes are nanoscale vesicles derived from various cell types and tissues that have many potential applications, generating great interest from researchers. One particularly intriguing application of exosomes is their use as a direct therapeutic for aesthetic indications. Several studies and case reports have explored the impact of exosomes for numerous cosmetic concerns but a consensus on the outcomes of these studies has not been established. Aims: In this review, we summarize the proposed mechanism of action, application, and efficacy of treatments with exosomes for alopecia and hair rejuvenation, facial rejuvenation, hyperpigmentation, and scarring. Methods: We conducted a comprehensive literature review on the use of exosomes for the treatment of alopecia and hair rejuvenation, facial rejuvenation, hyperpigmentation, and scarring. Additionally, several practical clinical cases where exosomes were applied for these indications were included. Results: The general consensus from the literature review showed that the early evidence supports the efficacy of exosomes for the treatment of alopecia, facial rejuvenation, hyperpigmentation, and scarring. The clinical cases included demonstrated promising improvements in the patients that received treatment. Several limitations regarding the lack of standardization in the production and application of exosomes may limit their current use until more studies are conducted. Conclusions: Exosomes may serve as a potentially beneficial therapeutic option for several aesthetic dermatologic indications but further investigation is required to fully characterize the scope of their application.
- 7 January 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (1) , e16766
Top Cited PapersOpen AccessExosomes for Aesthetic Dermatology: A Comprehensive Literature Review and Update
Background: Exosomes are nanoscale vesicles derived from various cell types and tissues that have many potential applications, generating great interest from researchers. One particularly intriguing application of exosomes is their use as a direct therapeutic for aesthetic indications. Several studies and case reports have explored the impact of exosomes for numerous cosmetic concerns but a consensus on the outcomes of these studies has not been established. Aims: In this review, we summarize the proposed mechanism of action, application, and efficacy of treatments with exosomes for alopecia and hair rejuvenation, facial rejuvenation, hyperpigmentation, and scarring. Methods: We conducted a comprehensive literature review on the use of exosomes for the treatment of alopecia and hair rejuvenation, facial rejuvenation, hyperpigmentation, and scarring. Additionally, several practical clinical cases where exosomes were applied for these indications were included. Results: The general consensus from the literature review showed that the early evidence supports the efficacy of exosomes for the treatment of alopecia, facial rejuvenation, hyperpigmentation, and scarring. The clinical cases included demonstrated promising improvements in the patients that received treatment. Several limitations regarding the lack of standardization in the production and application of exosomes may limit their current use until more studies are conducted. Conclusions: Exosomes may serve as a potentially beneficial therapeutic option for several aesthetic dermatologic indications but further investigation is required to fully characterize the scope of their application.
- Open Access
- 18 September 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (S3) , 1-11
Real‐World Experience Using a Multi‐Modality System using Intense Pulsed Light, Radiofrequency Microneedling, High‐Intensity Focused Ultrasound, or Thermal Radiofrequency, 808, HIFU for Skin Rejuvenation Treatment
Background: Medical aesthetic procedures for facial rejuvenation with laser and energy‐based devices (EBDs) are rapidly increasing. The following cases highlight real‐life experience using a multi‐modality system with various handpieces that combine intense pulsed light (IPL), laser hair removal (808 diode), high‐intensity focused ultrasound (HIFU), radiofrequency microneedling (RFM), and thermal radiofrequency (RF) for antiaging and rejuvenation treatment. Laser and RFM treatments may improve skin conditions by inducing cutaneous changes that remodel the skin matrix.Methods: Six physicians who treat patients for skin rejuvenation reported on clinical cases from their practice using a multi‐modality system with various handpieces.Results: During the meeting, the advisors discussed 15 cases and agreed to select seven patients with different ages and skin phototypes receiving various treatments for photodamage of the face, neck, and décolleté. The advisors discussed why they selected the case, previous treatment, type of treatment, results, and clinical pearls.Conclusion: Sharing best practices in medical aesthetics using combination treatments on a single multi‐modality energy‐based device such as laser and MRF for facial, neck, and chest skin may support healthcare providers treating patients for skin rejuvenation to improve clinical outcomes.
- 18 September 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (S3) , 1-11
Open AccessReal‐World Experience Using a Multi‐Modality System using Intense Pulsed Light, Radiofrequency Microneedling, High‐Intensity Focused Ultrasound, or Thermal Radiofrequency, 808, HIFU for Skin Rejuvenation Treatment
Background: Medical aesthetic procedures for facial rejuvenation with laser and energy‐based devices (EBDs) are rapidly increasing. The following cases highlight real‐life experience using a multi‐modality system with various handpieces that combine intense pulsed light (IPL), laser hair removal (808 diode), high‐intensity focused ultrasound (HIFU), radiofrequency microneedling (RFM), and thermal radiofrequency (RF) for antiaging and rejuvenation treatment. Laser and RFM treatments may improve skin conditions by inducing cutaneous changes that remodel the skin matrix.Methods: Six physicians who treat patients for skin rejuvenation reported on clinical cases from their practice using a multi‐modality system with various handpieces.Results: During the meeting, the advisors discussed 15 cases and agreed to select seven patients with different ages and skin phototypes receiving various treatments for photodamage of the face, neck, and décolleté. The advisors discussed why they selected the case, previous treatment, type of treatment, results, and clinical pearls.Conclusion: Sharing best practices in medical aesthetics using combination treatments on a single multi‐modality energy‐based device such as laser and MRF for facial, neck, and chest skin may support healthcare providers treating patients for skin rejuvenation to improve clinical outcomes.